Satoru Suzuki

5.1k citations
240 papers · 3.7k indexed · h-index 31

Satoru Suzuki

225 papers receiving 3.5k citations

Peers

Satoru Suzuki
Comparison fields: 5 of 146
  • Endocrinology, Diabetes and Metabolism 1.0k
  • Nephrology 298
  • Pharmaceutical Science 134
  • Radiological and Ultrasound Technology 112
  • Endocrine and Autonomic Systems 140
Replace Kim Henriksen with:
Kim Henriksen Denmark
Hong Ruan China
Hiroaki Miyajima Japan
Yasushi Sato Japan
Germano Guerra Italy
D. Schrijvers Belgium
Jing Zhou China
Qin Zhang China
Henrik Birn Denmark
Piotr Dzięgiel Poland
Satoru Suzuki relative to Kim Henriksen Denmark Kim Henriksen's profile →
Citations per field
00.5×10×20×28×
Kim Henriksen · 1×
Citations per year

Countries citing papers authored by Satoru Suzuki

Since Specialization
Citations

This map shows the geographic impact of Satoru Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Suzuki more than expected).

Fields of papers citing papers by Satoru Suzuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Suzuki. The network helps show where Satoru Suzuki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Satoru Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Satoru Suzuki Line = papers co-authored together Satoru Suzuki links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 202410
3 20233
4 20227
5 20216
6 202037
7 201913
8 201719
9 201714
10 20173
11 200815
12 200628
13 20052
14
20022
15 20022
16 199915
17 199410
18 19913
19
Dipyridamole reduces urinary albumin excretion in diabetic patients with normo- or microalbuminuria.
199018
20 19872

About Satoru Suzuki

Satoru Suzuki is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 240 papers that have together received 3.7k indexed citations. Recurring topics across this work include Thyroid Disorders and Treatments (22 papers), Renal Diseases and Glomerulopathies (21 papers), Radiation Dose and Imaging (19 papers), Thyroid Cancer Diagnosis and Treatment (17 papers), Growth Hormone and Insulin-like Growth Factors (16 papers), Radioactive contamination and transfer (15 papers), Cardiovascular Function and Risk Factors (14 papers) and Heart Failure Treatment and Management (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.0k citations), Nephrology (298 citations) and Pharmaceutical Science (134 citations). Satoru Suzuki has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Takahide Miyamoto, Kiyoshi Hashizume, Teiji Takeda, Fumitake Gejyo, Hideki Kimura, Leslie J. DeGroot, Kazuo Ichikawa, Hiroki Shimura, Mutsuhiro Kobayashi and Shinichi Suzuki.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026